Publications of Ulrike Schmidt
All genres
Journal Article (54)
2014
Journal Article
15, 195 (2014)
Developmentally adapted cognitive processing therapy for adolescents and young adults with PTSD symptoms after physical and sexual abuse: study [Study Protocol] protocol for a randomized controlled trial. TRIALS
Journal Article
23 (2), pp. 176 - 185 (2014)
Deficiency of FK506-binding protein ( FKBP) 51 alters sleep architecture and recovery sleep responses to stress in mice. JOURNAL OF SLEEP RESEARCH 2013
Journal Article
8 (3), e60219 (2013)
Identification of a Role for the Ventral Hippocampus in Neuropeptide S-Elicited Anxiolysis. PLOS ONE
Journal Article
35 (1), pp. 43 - 54 (2013)
Biomarkers in Posttraumatic Stress Disorder: Overview and Implications for Future Research. DISEASE MARKERS 2012
Journal Article
37 (6), pp. 1323 - 1337 (2012)
Intranasally Administered Neuropeptide S (NPS) Exerts Anxiolytic Effects Following Internalization Into NPS Receptor-Expressing Neurons. Neuropsychopharmacology
Journal Article
62 (1), pp. 332 - 339 (2012)
The involvement of FK506-binding protein 51 (FKBP5) in the behavioral and neuroendocrine effects of chronic social defeat stress. Neuropharmacology
Journal Article
441, pp. 297 - 303 (2012)
BAG-1 diversely affects steroid receptor activity. Biochemical Journal 2011
Journal Article
70 (10), pp. 928 - 936 (2011)
FK506 Binding Protein 5 Shapes Stress Responsiveness: Modulation of Neuroendocrine Reactivity and Coping Behavior. Biological Psychiatry
Journal Article
44 (6), p. 284 - 284 (2011)
Searching for biomarkers in a historic sample of Amyotrophic Lateral Sclerosis - The Munich Historic Brain Bank Project. Pharmacopsychiatry
Journal Article
44 (6), p. 287 - 287 (2011)
Functional characterization of single-nucleotide polymorphisms in the HAB/LAB mouse Tmem132d promoter. Pharmacopsychiatry
Journal Article
21 (Suppl. 3), pp. S189 - S190 (2011)
The involvement of FK506-binding protein 51 (FKBP51) in the behavioural and neuroendocrine effects of acute and chronic stress. European Neuropsychopharmacology
Journal Article
44 (6), p. 294 - 294 (2011)
The involvement of FKBP51 and FKBP52 in the behavioural and neuroendocrine effects of acute and chronic stress. Pharmacopsychiatry
Journal Article
44 (6), p. 295 - 295 (2011)
Decreased expression of synaptic proteins in a mouse model of posttraumatic stress disorder. Pharmacopsychiatry
Journal Article
21 (Suppl. 1), pp. S8 - S9 (2011)
The involvement of FK506-binding protein 51 gene (FKBP51) in the behavioural and neuroendocrine effects of acute and chronic stress. European Neuropsychopharmacology
Journal Article
45 (5), pp. 650 - 659 (2011)
Reduced hippocampus volume in the mouse model of Posttraumatic Stress Disorder. Journal of Psychciatric Research
Journal Article
30 (2-3), pp. 77 - 87 (2011)
Epigenetic aspects of posttraumatic stress disorder. Disease Markers 2010
Journal Article
15 (2), pp. 223 - 231 (2010)
Die Posttraumatische Belastungsstörung - ein Resultat dysfunktionaler epigenetischer Adaptionsprozesse? Psychotherapie
Journal Article
15 (2), pp. 317 - 321 (2010)
Besonderheiten der Traumpsychotherapie von Soldaten und Kriegsveteranen - Ein Erfahrungsbericht. Psychotherapie 2009
Journal Article
42 (5), p. 214 - 214 (2009)
Biomarkers in a mouse model of posttraumatic stress disorder. Pharmacopsychiatry
Journal Article
42 (5), p. 221 - 221 (2009)
The involvement of FKBP5 in the behavioural and neuroendocrine effects of acute and chronic stress. Pharmacopsychiatry